U
Revium Rx RVRC
$0.50 $0.098924.66%
Recommendation
--
Prev Close
--
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
--

09/30/2010 06/30/2010 03/31/2010 09/30/2009
Revenue -- -- -- --
Total Other Revenue -- -- -- --
Total Revenue -- -- -- --
Cost of Revenue -- -- -- --
Gross Profit -- -- -- --
SG&A Expenses 4,955.56% 24.12% -96.69% -97.33%
Depreciation & Amortization -- -- -- --
Other Operating Expenses -- -- -- --
Total Operating Expenses 4,955.56% -16.77% -99.33% -99.58%
Operating Income -4,955.56% -55.63% 90.78% -205.88%
Income Before Tax -4,955.56% -55.63% 90.78% -205.88%
Income Tax Expenses -- -- -- --
Earnings from Continuing Operations -4,955.56% -55.63% 90.78% -205.88%
Earnings from Discontinued Operations -- -- -- --
Extraordinary Item & Accounting Change -- -- -- --
Minority Interest in Earnings -- -- -- --
Net Income -4,955.56% -55.63% 90.78% -205.88%
EBIT -4,955.56% -55.63% 90.78% -205.88%
EBITDA -- -- -- --
EPS Basic -3,384.86% -9.01% 90.89% -326.13%
Normalized Basic EPS -3,381.95% -8.99% 90.89% -326.44%
EPS Diluted -3,384.86% -9.01% 90.89% -326.13%
Normalized Diluted EPS -3,381.95% -8.99% 90.89% -326.44%
Average Basic Shares Outstanding 46.41% 42.83% 1.16% -52.98%
Average Diluted Shares Outstanding 46.41% 42.83% 1.16% -52.98%
Dividend Per Share -- -- -- --
Payout Ratio -- -- -- --
Weiss Ratings